Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1917 1
1918 3
1920 1
1922 2
1928 4
1931 1
1932 2
1934 3
1935 1
1936 5
1937 6
1938 4
1939 5
1940 5
1941 5
1942 5
1943 3
1944 5
1945 22
1946 20
1947 27
1948 24
1949 38
1950 43
1951 42
1952 44
1953 57
1954 59
1955 85
1956 87
1957 87
1958 86
1959 94
1960 104
1961 159
1962 201
1963 373
1964 645
1965 361
1966 358
1967 408
1968 453
1969 667
1970 593
1971 652
1972 689
1973 701
1974 765
1975 825
1976 843
1977 807
1978 780
1979 739
1980 784
1981 702
1982 817
1983 895
1984 1030
1985 1152
1986 1097
1987 1191
1988 1232
1989 1270
1990 1459
1991 1542
1992 1631
1993 1603
1994 1739
1995 1826
1996 1838
1997 2000
1998 2072
1999 2404
2000 2453
2001 2420
2002 2412
2003 2681
2004 2916
2005 3213
2006 3485
2007 3692
2008 3658
2009 3899
2010 4140
2011 4603
2012 4746
2013 4875
2014 4983
2015 5155
2016 5090
2017 5157
2018 5138
2019 5282
2020 6519
2021 9781
2022 11775
2023 9227
2024 2548

Text availability

Article attribute

Article type

Publication date

Search Results

149,031 results

Results by year

Filters applied: . Clear all
Page 1
Vaccination and Antibody Testing in Cats.
Egberink H, Frymus T, Hartmann K, Möstl K, Addie DD, Belák S, Boucraut-Baralon C, Hofmann-Lehmann R, Lloret A, Marsilio F, Pennisi MG, Tasker S, Thiry E, Truyen U, Hosie MJ. Egberink H, et al. Viruses. 2022 Jul 22;14(8):1602. doi: 10.3390/v14081602. Viruses. 2022. PMID: 35893667 Free PMC article. Review.
Vaccines protect cats from serious diseases by inducing antibodies and cellular immune responses. ...In adult cats, antibody test results can inform the appropriate re-vaccination interval. ...
Vaccines protect cats from serious diseases by inducing antibodies and cellular immune responses. ...In adult cats, antibod …
COVID-19 vaccines: Immune correlates and clinical outcomes.
Mahrokhian SH, Tostanoski LH, Vidal SJ, Barouch DH. Mahrokhian SH, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2324549. doi: 10.1080/21645515.2024.2324549. Epub 2024 Mar 22. Hum Vaccin Immunother. 2024. PMID: 38517241 Free PMC article. Review.
Severe disease due to COVID-19 has declined dramatically as a result of widespread vaccination and natural immunity in the population. With the emergence of SARS-CoV-2 variants that largely escape vaccine-elicited neutralizing antibody responses, the efficacy …
Severe disease due to COVID-19 has declined dramatically as a result of widespread vaccination and natural immunity in the population …
Dengue vaccine development: status and future.
Wilder-Smith A. Wilder-Smith A. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):40-44. doi: 10.1007/s00103-019-03060-3. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 31784763 Free PMC article. Review.
Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decades of research, the first dengue vaccine was licensed in 2015: CYD-TDV, a tetravalent live attenuated vaccine with a yellow fev …
Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decade …
The distinct impact of maternal antibodies on the immunogenicity of live and recombinant rotavirus vaccines.
Yang H, Luo G, Zeng Y, Li Y, Yu S, Zhao B, An R, Zhang S, Wang Y, Li T, Ge S, Xia N. Yang H, et al. Vaccine. 2019 Jul 9;37(30):4061-4067. doi: 10.1016/j.vaccine.2019.05.086. Epub 2019 Jun 7. Vaccine. 2019. PMID: 31182323
Although some studies show a negative correlation between maternal antibody levels and seroconversion after vaccination, withholding breastfeeding does not improve rotavirus vaccine efficacy. ...In this study, the impact of maternal antibodies on live …
Although some studies show a negative correlation between maternal antibody levels and seroconversion after vaccination, withh …
The protection conferred against virulent Newcastle disease virus (vNDV) genotype VII by commercial double recombinant HVT vaccines and NDV live-attenuated vaccine as prime/boost vaccination regimens in commercial broiler chickens carrying maternally-derived antibodies (MDAs) against NDV.
Ghanem IAE, Abdullatif TM, Hassanin O. Ghanem IAE, et al. Avian Pathol. 2023 Aug;52(4):251-263. doi: 10.1080/03079457.2023.2211548. Epub 2023 Jun 8. Avian Pathol. 2023. PMID: 37158499
In commercial broilers with maternally-derived antibodies (MDAs) the efficacy of the rHVT-NDV-IBDV vaccines was evaluated when administered alone, in combination with live-attenuated NDV vaccine at one-day-old, or as part of a prime/boost strategy. ...Both co …
In commercial broilers with maternally-derived antibodies (MDAs) the efficacy of the rHVT-NDV-IBDV vaccines was evaluated when …
Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals.
Zaeck LM, Lamers MM, Verstrepen BE, Bestebroer TM, van Royen ME, Götz H, Shamier MC, van Leeuwen LPM, Schmitz KS, Alblas K, van Efferen S, Bogers S, Scherbeijn S, Rimmelzwaan GF, van Gorp ECM, Koopmans MPG, Haagmans BL, GeurtsvanKessel CH, de Vries RD. Zaeck LM, et al. Nat Med. 2023 Jan;29(1):270-278. doi: 10.1038/s41591-022-02090-w. Epub 2022 Oct 18. Nat Med. 2023. PMID: 36257333 Free PMC article.
Modified vaccinia Ankara-Bavarian Nordic (MVA-BN, also known as Imvamune, JYNNEOS or Imvanex) is a third-generation smallpox vaccine that is authorized and in use as a vaccine against MPX. To date, there are no data showing MPX virus (MPXV)-neutralizing antibodie …
Modified vaccinia Ankara-Bavarian Nordic (MVA-BN, also known as Imvamune, JYNNEOS or Imvanex) is a third-generation smallpox vaccine …
Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children.
Feng G, Kurtovic L, Agius PA, Aitken EH, Sacarlal J, Wines BD, Hogarth PM, Rogerson SJ, Fowkes FJI, Dobaño C, Beeson JG. Feng G, et al. BMC Med. 2022 Aug 25;20(1):289. doi: 10.1186/s12916-022-02466-2. BMC Med. 2022. PMID: 36002841 Free PMC article. Clinical Trial.
However, vaccine efficacy is modest and short-lived. Antibodies play the major role in vaccine-induced immunity, but knowledge on the induction, decay, and determinants of antibody function is limited, especially among children. ...Induction of functio …
However, vaccine efficacy is modest and short-lived. Antibodies play the major role in vaccine-induced immunity, but kn …
COVID-19-Impfungen: Replizierend oder Nichtreplizierend?
Klimek L, Chaker AM, Cuevas M, Becker S. Klimek L, et al. Laryngorhinootologie. 2021 Aug;100(8):603-607. doi: 10.1055/a-1509-8916. Epub 2021 May 27. Laryngorhinootologie. 2021. PMID: 34044465 German.
The Gamaleya institute developed the COVID-19 vaccine named Sputnik (Gam-COVID-Vac) using adenoviral vectors ad 26 and ad5 to incorporate a full SARS-Spike Protein for vaccination. ...Patient subgroups and vaccination efficacy in healthy vaccinated may …
The Gamaleya institute developed the COVID-19 vaccine named Sputnik (Gam-COVID-Vac) using adenoviral vectors ad 26 and ad5 to incorpo …
Augmented neutralization of SARS-CoV-2 Omicron variant by boost vaccination and monoclonal antibodies.
Schulz SR, Hoffmann M, Roth E, Pracht K, Burnett DL, Mazigi O, Schuh W, Manger B, Mielenz D, Goodnow CC, Christ D, Pöhlmann S, Jäck HM. Schulz SR, et al. Eur J Immunol. 2022 Jun;52(6):970-977. doi: 10.1002/eji.202249841. Epub 2022 Mar 23. Eur J Immunol. 2022. PMID: 35253229 Free PMC article.
Effective vaccines and monoclonal antibodies have been developed against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ...Therefore, a third vaccination is warranted to increase titers of protectiv …
Effective vaccines and monoclonal antibodies have been developed against coronavirus disease 2019 (COVID-19) caused by severe …
Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults.
Sanz-Muñoz I, Lajara C, Sánchez-Martínez J, Prada-García C, Rojo-Rello S, Domínguez-Gil M, Fernández-Espinilla V, Hernán-García C, Eiros-Bachiller JM, Caminero-Pérez A, Marcos-López Y, Teso-Fernández L, Echarren JI, Castrodeza-Sanz J, Eiros JM. Sanz-Muñoz I, et al. Hum Vaccin Immunother. 2023 Aug 1;19(2):2236537. doi: 10.1080/21645515.2023.2236537. Hum Vaccin Immunother. 2023. PMID: 37528765 Free PMC article.
The dynamics of antibodies were analyzed. A lower seroprotection of NV before vaccination was observed, but an antibody response between 2 and 4 times higher than in V was assessed. ...Adults never vaccinated against influenza had lower seroprotection …
The dynamics of antibodies were analyzed. A lower seroprotection of NV before vaccination was observed, but an antibody …
149,031 results
You have reached the last available page of results. Please see the User Guide for more information.